Program

09:45-10:00: ASM Opening Address
(Dr Ashish Gulve, President, NSUKI)
Theme: Basic Science
10:00-10:30: Chair: Mechanisms of action of Spinal Cord Stimulation: Dr Ilona Obara, Newcastle
10:30-11:00: Dorsal Horn Dendrite Stimulation: Dr Marc Russo, President, International Neuromodulation Society,
NSW, Australia
11:00-11:30: Tea & Coffee/Exhibition
11:30-12:00: Chair Transcutaneous Vagal Nerve Stimulation: Prof Jim Deuchars, Leeds
12:00-12:30: Free Oral Presentations
12:30-13:00: Chair Industry Sponsored Satellite Symposium (Mainstay Medical)
Neuromuscular Instability (Dr Ben Goss, Director of Research, The Netherlands)
13:00-14:00: LUNCH
14:00-14:30: Free Oral Presentations
14:30-15:00: Chair Industry Sponsored Satellite Symposium (Medtronic)
Role of SCS in PSPS type-1, what evidence suggests?
(Dr Vivek Mehta and Dr Kavita Poply, Barts Health NHS Trust, London)
15:00-15:30: Industry Sponsored Satellite Symposium (Boston Scientific)
“Living life in the FASTTM Lane”
(Dr Neil Collighan, Consultant in Pain Management and Neuromodulation,
East Kent Hospitals University NHS Foundation Trust, Kent)
15:30-16:00: Tea & Coffee/Exhibition
Theme: Cancer Pain
16:00-16:30: Chair Intrathecal Drug Delivery for Cancer Pain: Dr Matthew Brown, London
16:30-17:00: PACC Guidelines and Cancer Pain: Dr Anu Kansal, Middlesbrough
17:00-17:30: Setting up Cancer Pain Service: Dr Somnath Bagchi, Plymouth
17:30-18:00: Neuromodulation in Cancer Survivors: Dr Sheila Black, Leeds & Dr Ashish Gulve, Middlesbrough
18:00-19:00: NSUKI AGM
20:30-22:30: NSUKI ASM DINNER (GATESHEAD SUITE)
Saturday, 5 November 2022
08:00-08:30: Registration/Tea & Coffee/Exhibition
08:00-08:30: Free Oral Presentations
08:30-09:00: Industry Sponsored Satellite Symposium (Nevro)
10 Years of 10kHz: A Decade of Data (Dr Iris Smet, Belgium)
Theme: Clinical Trials
09:00-09:30: CHAIR: Infection Control for Implantable Therapies - What is State of the Art?
Dr Marc Russo, President, International Neuromodulation Society, NSW, Australia
09:30-10:00: Prospective, Randomised, Crossover, Controlled, Feasibility Study to Assess the Efficacy of BurstDR Spinal
Cord Stimulation (SCS) as a Treatment for Persistent Abdominal Refractory Visceral Pain Secondary to
Chronic Pancreatitis: PANACEA Trial: Dr Ganesan Baranidharan, Leeds
10:00-10:30: Industry Sponsored Satellite Symposium (Abbott)
‘Neuromodulation Update 2022’
(Dr Allen W. Burton, Divisional Vice President, Medical Director, Neuromodulation, Abbott, USA)
10:30-11:00: Tea & Coffee/Exhibition
Theme: Controversies in Neuromodulation
11:00-11:30: CHAIR: Thoracic Spine Magnetic Resonance Imaging Should Be an Absolute Requirement Prior to SCS Lead
Insertion. Pro: Mr Girish Vajramani, Southampton Con: Dr David Pang, London
11:30-12:00: What System for Whom? Prof Sam Eldabe, Middlesbrough, UK/Morges, Switzerland
12:00-12:30: “FBSS” an obsolete nomenclature. Mr Brian Simpson, Cardiff, Wales
12:30-13:00: Citation & Award ‘NSUKI Lifetime Achievement Award’
13:30-14:00: Lunch/Exhibition
Theme: Education & Developments
14:00-14:30: CHAIR: Past, Present and Future of Peripheral Neuromodulation: Dr Teodor Goroszeniuk, London
14:30-15:00: National Neuromodulation Registry Phase 2: Dr G. Baranidharan, Leeds & Prof James FitzGerald, Oxford
15:00-15:30: Queen Mary University Post Graduate Certificate Course in Neuromodulation:
Dr Kavita Poply & Dr Vivek Mehta, London
15:30-16:00: Post-covid Innovative SCS pathways: Ms J. Jennings, Leeds, Ms A Cox, Liverpool & Mr R. Wilding, Salford
16:00-16:30: Free Oral Presentations
16:30-17:00: Dr Peter Toomey Best Poster Award & Closing Remarks